Matthew Goldfarb - May 6, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
Director
Signature
Jonathan B. Leiken, Attorney-in-fact for Matthew Goldfarb
Stock symbol
DBD
Transactions as of
May 6, 2022
Transactions value $
$0
Form type
4
Date filed
5/10/2022, 04:55 PM
Previous filing
Nov 16, 2021
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Award $0 +30.9K +35.03% $0.00 119K May 6, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes restricted stock units.